Corpus Intelligence IC Memo — HARRIS PSYCHIATRIC HOSPITAL 2026-04-26 09:07 UTC
IC Memo — HARRIS PSYCHIATRIC HOSPITAL
Investment Committee Memorandum | SC | 98 beds | Grade C | EBITDA uplift $1.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HARRIS PSYCHIATRIC HOSPITAL

CCN 424011 | RICHLAND, SC | 98 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HARRIS PSYCHIATRIC HOSPITAL is a 98-bed under-performing / distressed in RICHLAND, SC with $16.7M in net patient revenue and a -84.8% operating margin. The hospital serves a payer mix of 1.2% Medicare, 7.1% Medicaid, and 91.7% commercial.

Thesis: Turnaround. Our ML models identify $1.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -84.8% to -77.5% (+736bps).

Net Revenue HCRIS$16.7M
Current EBITDA COMPUTED$-14.2M
Operating Margin COMPUTED-84.8%
Occupancy HCRIS97.3%
Revenue / Bed COMPUTED$171K
Net-to-Gross HCRIS56.7%
Distress Probability ML41.3%

2. Market Context & Competitive Position

85
SC Hospitals
1.3%
State Median Margin
35
Comparable Hospitals

SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of -84.8% places it below the state median. Among 35 size-comparable peers (49-196 beds), the median margin is 8.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (49-196), prioritizing same-state peers. 35 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HARRIS PSYCHIATRIC HOSPITAL (Target)SC98$16.7M-84.8%
BON SECOURS ST. FRANCIS XAVIERSC186$304.6M12.2%
BEAUFORT MEMORIAL HOSPITALSC167$269.0M-7.3%
MCLEOD LORIS SEACOAST HOSPITALSC155$262.3M10.1%
MUSC HEALTH FLORENCE MEDICAL CSC187$252.9M-6.9%
CONWAY HOSPITALSC171$250.2M-14.7%
PH PATEWOOD HOSPITALSC64$229.8M38.0%
EAST COOPER REGIONAL MEDICAL CSC120$206.1M28.3%
OCONEE MEMORIAL HOSPITALSC131$190.4M5.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$351K+210bp18mo
Cost to Collect4.5%2.5%$334K+200bp12mo
Denial Rate Reduction12.0%6.5%$331K+198bp12mo
A/R Days Reduction5200.0%3800.0%$203K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$351K
Cost to Collect
$334K
Denial Rate Reduction
$331K
A/R Days Reduction
$203K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.2M
Current EBITDA$-14.2M
+ RCM Uplift+$1.2M
Pro Forma EBITDA$-13.0M
Current Margin-84.8%
Pro Forma Margin-77.5%
WC Released (1x)$641K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-21.8M$-81.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-21.8M$-96.5M0.00x-100.0%
Bull Case9.0x11.0x$-19.6M$-99.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-19.6M$-114.3M0.00x-100.0%
Bear Case11.0x10.0x$-24.0M$-80.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-24.0M$-96.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 35 hospitals with 49-196 beds
  • Same-state prioritization (n=36)
  • Comp margins: P25=-7.2% / P50=8.3% / P75=19.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.